EdgarLookup

Intellia Therapeutics, Inc. — All Filings

683 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 144 3 4 4/A 424B4 424B5 8-A12B 8-K ARS CERTNAS CORRESP CT ORDER D DEF 14A DEFA14A DRS DRS/A EFFECT FWP POS AM POSASR PRE 14A S-1 S-1/A S-1MEF S-3 S-3/A S-3ASR S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
4 FORM 4 SUBMISSION 0001209191-20-032648 May 28, 2020 May 26, 2020
8-K 8-K 0001564590-20-022377 May 7, 2020
10-Q 10-Q 0001564590-20-022919 May 7, 2020 Mar 31, 2020
3 FORM 3 SUBMISSION 0001209191-20-027162 May 5, 2020 Apr 30, 2020
4 FORM 4 SUBMISSION 0001209191-20-027165 May 5, 2020 May 1, 2020
DEF 14A DEF 14A 0001564590-20-018482 Apr 24, 2020 Jun 18, 2020
DEFA14A DEFA14A 0001564590-20-018497 Apr 24, 2020
8-K 8-K 0001564590-20-016142 Apr 9, 2020 Apr 3, 2020
SC 13D/A SC 13D/A 0001104659-20-040260 Mar 30, 2020
8-K 8-K 0001564590-20-012963 Mar 26, 2020
8-K 8-K ALBANY LEASE 0001564590-20-010859 Mar 13, 2020 Mar 12, 2020
4 FORM 4 SUBMISSION 0000899243-20-006978 Mar 4, 2020 Mar 2, 2020
4 FORM 4 SUBMISSION 0000899243-20-006975 Mar 4, 2020 Mar 2, 2020
4 FORM 4 SUBMISSION 0000899243-20-006973 Mar 4, 2020 Jan 3, 2020
4 FORM 4 SUBMISSION 0000899243-20-006976 Mar 4, 2020 Mar 2, 2020
4 FORM 4 SUBMISSION 0000899243-20-006979 Mar 4, 2020 Mar 2, 2020
10-K 10-K 0001564590-20-007409 Feb 27, 2020 Dec 31, 2019
S-8 S-8 0001564590-20-007444 Feb 27, 2020
8-K 8-K Q419 EARNINGS RELEASE 0001564590-20-007032 Feb 27, 2020
SC 13G/A SCHEDULE 13G/A 0001104659-20-021151 Feb 14, 2020
SC 13G/A SCHEDULE 13G/A 0001104659-20-018572 Feb 12, 2020
SC 13G/A FORM SC 13G/A 0000950103-20-002663 Feb 12, 2020
SC 13G/A SC 13G/A 0001140361-20-002973 Feb 12, 2020
SC 13G/A 0000834237-20-005186 Feb 5, 2020
8-K 8-K FOR PRELIM 2019 RESULTS AND PRESS RELEASE 0001564590-20-000550 Jan 9, 2020
8-K 8-K 0001193125-19-314363 Dec 16, 2019 Dec 13, 2019
8-K 8-K 0001193125-19-279632 Oct 31, 2019
10-Q 10-Q 0001564590-19-039199 Oct 31, 2019 Sep 30, 2019
8-K 8-K 0001193125-19-256137 Sep 26, 2019
EFFECT 9999999995-19-002079 Sep 12, 2019
SC 13G/A 0000315066-19-001705 Sep 10, 2019
CORRESP 0001193125-19-241975 Sep 10, 2019
S-3/A S-3/A 0001193125-19-235380 Aug 30, 2019
CORRESP 0001193125-19-235386 Aug 30, 2019
UPLOAD 0000000000-19-012968 Aug 29, 2019
S-3 S-3 0001193125-19-228025 Aug 23, 2019
SC 13G/A AMENDMENT NO. 1 0001214659-19-005075 Aug 8, 2019
SC 13G/A SC 13G/A 0001140361-19-014318 Aug 6, 2019
4 FORM 4 SUBMISSION 0001209191-19-044238 Aug 2, 2019 Aug 1, 2019
8-K 8-K 0001193125-19-209778 Aug 1, 2019
10-Q 10-Q JUNE 2019 0001564590-19-028042 Aug 1, 2019 Jun 30, 2019
SC 13G 0001214659-19-004547 Jul 9, 2019
SC 13G SC 13G 0001140361-19-012576 Jul 9, 2019
EFFECT 9999999995-19-001290 Jun 6, 2019
CORRESP 0001193125-19-165029 Jun 4, 2019
4 FORM 4 SUBMISSION 0001209191-19-034240 Jun 4, 2019 Jun 3, 2019
3 FORM 3 SUBMISSION 0001209191-19-033187 May 29, 2019 May 28, 2019
4 FORM 4 SUBMISSION 0001209191-19-032086 May 22, 2019 May 21, 2019
4 FORM 4 SUBMISSION 0001209191-19-032084 May 22, 2019 May 21, 2019
4 FORM 4 SUBMISSION 0001209191-19-032081 May 22, 2019 May 21, 2019